GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.40
Bid: 29.20
Ask: 29.90
Change: -0.35 (-1.18%)
Spread: 0.70 (2.397%)
Open: 29.50
High: 30.00
Low: 29.40
Prev. Close: 29.75
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

19 Apr 2006 07:00

Embargoed: 19th April 2006, 07:00hrs International Brand Licensing Plc ("IBL" or the "Company") Final Results to the year ended 31 December 2005 Chairman's StatementHighlights: * Turnover for the year ended 31 December 2005 increased by ‚£1,026,000 to ‚£ 3,261,000 (2004: ‚£2,235,000) * Profit on ordinary activities before tax improved by ‚£1,482,000 to a profit of ‚£977,000 (2004: loss of ‚£505,000) * A gain of ‚£475,000 was made on the sale of the Mountain Equipment trademarks * Record sales of England replica kit and substantial growth opportunities ahead For the year ended 31st December 2005 I am delighted to report a substantialturnaround in the Group's fortunes. 2005 was a year of consolidation, cuttingoverheads, improving gross margin, eliminating debt, and producing a full yearprofit for the first time in the Group's history.The 45% increase in turnover is attributable to the exceptional sales of theAdmiral England cricket replica kit that increased by 90% to a record level of‚£2,525,000 for the year. Boosted by England's tremendous Ashes win overAustralia, the Admiral brand enjoyed unprecedented visibility throughout theyear, and this continued unabated this winter, culminating in the marvellousthird Test victory over India in March 2006.With the return Ashes Series in Australia this winter, followed by the ICCCricket World Cup in the Caribbean and the India UK tour next summer, the levelof exposure that will continue to be generated for Admiral will further enhancethe profile and brand value for the future.Against a backdrop of difficult trading conditions in the UK retail sector thatfailed to recover through the year, Admiral sales at ASDA were some 15% down on2004. Certain product categories such as footwear and sports equipmentcontinued to perform well, but clothing suffered due to the heavy discountingthat plagued the UK market for much of the year. With the FIFA World Cup Finalsin Germany this summer we expect Admiral's first half clothing sales at ASDA toshow an overall improvement on 2005.In December the Company entered into a new strategic alliance with @miral BV,its licensee for Benelux, Germany, and Austria. As part of a new ten yearlicense agreement for this key central European territory, @miral will use itsextensive design, development, and marketing resources to develop seasonalprogrammes on an annual basis for IBL's network of international licensees.The Company continues to seek Admiral licensee partners in other majorinternational markets, particularly in several of the developing Asianeconomies where a significant amount of work has been undertaken. Negotiationsin certain markets are progressing well, and focus will continue to be appliedon untapped potential for the Admiral brand where opportunities for futuregrowth are substantial.IBL is now in a strong position to further enhance shareholder value. TheAdmiral brand continues to grow around the world, and as kit sponsors to theEngland and West Indies cricket teams we believe we have substantialopportunities in the years ahead. Your Board looks forward to the future withgreat confidence.ADAM REYNOLDSChairman19th April 2006For further information please contact:Adam ReynoldsPaul FoulgerInternational Brand Licensing plcTel: 020 7823 1733Katie Ratner/John PriorCorporate SynergyTel: 020 7448 4400Group Profit and Loss AccountFor the year ended 31 December 2005 2005 2004 ‚£000 ‚£000 Turnover 3,261 2,235 Cost of sales (1,286) (561) Gross Profit 1,975 1,674 Administrative expenses (1,402) (1,963) Operating Profit/(Loss) 573 (289) Exceptional profit on sale of intangible 475 -asset Interest receivable 6 - Interest payable (77) (216) Profit/(Loss) on ordinary activities before 977 (505)tax Tax on profit on ordinary activities (142) (84) Retained Profit/(Loss) for the year 835 (589) Earnings/(Loss) per ordinary share Before exceptional items - Basic 1.1p (1.9p) - Diluted 1.1p (1.9p) After exceptional items - Basic 2.5p (1.9p) - Diluted 2.5p (1.9p)Group statement of total recognised gains and lossesFor the year ended 31 December 2005 2005 2004 ‚£000 ‚£000 Profit/(Loss) for the year 835 (589) Exchange differences (236) 28 Total recognised gains and losses relating to the 599 (561)year Group balance sheetat 31 December 2005 2005 2004 ‚£000 ‚£000 Fixed assets Intangible assets 3,471 5,952 Tangible assets 9 15 3,480 5,967 Current assets Stock 252 217 Debtors 828 364 Cash at bank and in hand 283 109 1,363 690 Creditors: amounts falling due within one year (1,129) (3,542) Net current assets/(liabilities ) 234 (2,852) Total assets less current liabilities 3,714 3,115 Capital and reserves Share capital 333 333 Share premium 3,048 3,048 Merger reserve 244 244 Profit and loss account 89 (510) Shareholders' funds 3,714 3,115Group statement of cash flowsAt 31 December 2005 2005 2004 ‚£000 ‚£000 Net cash inflow/(outflow) from operating activities 111 (430) Returns on investments and servicing of finance Interest paid (80) (224) Interest received 6 - Taxation UK Tax paid (59) (198) Foreign taxes received 48 - Capital expenditure and financial investment Purchase of intangible fixed assets (37) (82) Capital Income Sale of intangible fixed assets 2,772 - Net cash inflow/(outflow) from capital expenditure 2,735 (82) and financial investment Net cash inflow/(outflow) before financing 2,761 (934) Financing Repayment of bank borrowing (2,563) (250) Issue of ordinary shares - 1,329 Less expenses of issue - (111) Net cash (outflow)/inflow from financing (2,563) 968 Increase in cash in the year 198 34The financial information set out in this announcement does not constitutestatutory accounts within the meaning of Section 240 of the Companies Act 1985.Statutory accounts for the period ended 31 December 2005, containing anunqualified auditors' report will be filed with the Registrar of Companies.The Directors do not propose a payment of a dividend.This preliminary statement was approved by the Board on 19 April 2006ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
7th Apr 20207:00 amRNSFinal Results
24th Mar 20207:00 amRNSDetailed trading review including COVID-19 update
20th Mar 20207:00 amRNSInvestor results briefing update
4th Mar 20207:00 amRNSNotice of Results
24th Feb 20201:56 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading update
6th Nov 201912:14 pmRNSTrading update and performance bonuses
10th Sep 20197:00 amRNSHalf-year Report
10th Sep 20197:00 amRNSPreferred Partner Arrangement with Mount Sinai
21st Aug 20197:00 amRNSNotice of Results
8th Aug 20194:40 pmRNSSecond Price Monitoring Extn
8th Aug 20194:35 pmRNSPrice Monitoring Extension
15th Jul 20197:00 amRNSTrading update
11th Jun 20192:15 pmRNSCancellation of share options
7th Jun 20194:30 pmRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 201911:21 amRNSResult of AGM
26th Apr 20196:20 pmRNSAcquisition of further interest in Renalytix AI
25th Apr 20197:00 amRNSPosting of AR & Accounts and Notice of AGM
13th Mar 20197:00 amRNSFinal Results
8th Mar 20197:00 amRNSNotice of Results
20th Feb 20197:00 amRNSUS FDA approval for Quo-Test analyser
22nd Jan 20197:00 amRNSUpdate on McKesson US distribution agreement
21st Jan 20197:00 amRNSClarification re. lock-up restrictions
16th Jan 20197:00 amRNSTrading update
20th Dec 20187:00 amRNSUpdate regarding planned change of NOMAD
19th Dec 20184:56 pmRNSPDMR dealing
7th Dec 20183:15 pmRNSPurchase of own shares and PDMR Dealing
30th Nov 20182:35 pmRNSTotal Voting Rights
22nd Nov 20185:13 pmRNSPurchase of own shares and PDMR Dealing
21st Nov 20182:08 pmRNSPurchase of own shares and PDMR Dealing
20th Nov 20185:18 pmRNSPurchase of own shares and PDMR Dealing
14th Nov 20182:20 pmRNSShare Buy-Back
9th Nov 20181:48 pmRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSRENX Admission to AIM and First Day of Dealings
2nd Nov 20188:00 amRNSSchedule 1 update - Renalytix AI plc
1st Nov 20185:30 pmRNSUpdate regarding AIM admission of RenalytixAI
31st Oct 20186:00 pmRNSResult of RO by RenalytixAI & Fundraising Update
23rd Oct 20182:00 pmRNSSchedule One Update - Renalytix AI plc
23rd Oct 201811:01 amRNSUpdate to distribution timetable
22nd Oct 20185:23 pmRNSApproval of distribution of shares in RenalytixAI
19th Oct 201812:10 pmRNSResult of General Meeting
19th Oct 201811:00 amRNSSchedule One - Renalytix AI plc
12th Oct 20187:00 amRNSInvestor presentation
11th Oct 20186:03 pmRNSLaunch of Restricted Offer by Renalytix AI plc
11th Oct 20185:21 pmRNSFundraising and AIM admission of Renalytix AI plc
11th Oct 20184:01 pmRNSFundraising and AIM admission of Renalytix AI plc
27th Sep 201810:15 amRNSNotice of GM
19th Sep 20187:00 amRNSHalf-year Report
17th Sep 201812:21 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.